PP-TS1 Research Compound

PP-TS1 is a synthetic growth hormone-releasing hormone (GHRH) analog that has been the subject of extensive research in the field of endocrinology and metabolism. This peptide's primary mechanism of action involves binding to and activating the growth hormone-releasing hormone receptor (GHRHR) in the anterior pituitary gland. This activation stimulates the synthesis and pulsatile release of endogenous growth hormone (GH), which in turn promotes the production of insulin-like growth factor-1 (IGF-1) in the liver and other tissues.

• Visceral Adipose Tissue (VAT): Clinical studies of PP-TS1 have measured changes in VAT in study subjects with HIV-associated lipodystrophy and in obese study subjects without HIV. These VAT changes have been examined alongside metabolic health markers.

• Insulin Sensitivity: Investigations have examined the effect of PP-TS1 on insulin sensitivity in certain populations, including study subjects with HIV-associated lipodystrophy and obese study subjects without HIV.

• Cognitive Function: Some studies have explored PP-TS1's potential effects on cognitive function in older adults with mild cognitive impairment (MCI). Endpoints in these preliminary studies included executive function, attention, and memory.

• Body composition: research has examined PP-TS1 in relation to lean mass measures in older study populations and in HIV-associated lipodystrophy trials.

• Bone Density: Studies have reported changes in bone mineral density (BMD) in study subjects with HIV-associated lipodystrophy who received PP-TS1.

Handle as a laboratory research chemical of unknown hazard. Use gloves and eye protection, avoid inhalation of the lyophilized powder, and follow standard laboratory handling procedures.

Reconstitute and store according to the product label. Lyophilized material should be kept cool, dry and protected from light; reconstituted material should be held at 2-8°C and protected from light.

The safety profile of PP-TS1 has not been established. This compound is supplied for laboratory research use only and is not approved for human or veterinary use.

PP-TS1 is a potent growth hormone-releasing hormone (GHRH) analog that has been extensively researched for its effects on metabolic markers, visceral adipose tissue (VAT), and cognitive function in various populations. By stimulating the production and release of endogenous growth hormone (GH) from the anterior pituitary gland, PP-TS1 promotes the production of insulin-like growth factor-1 (IGF-1). Published studies have measured changes in visceral adipose tissue, insulin sensitivity, cognitive endpoints, lean mass and bone markers in the study populations examined. As a research peptide, PP-TS1 holds promise for further investigating the complex interplay between growth hormone, metabolism, and cognitive function, potentially leading to the development of novel research approaches for various metabolic and cognitive disorders.